Drug
Ab598
Ab598: highest development phase Phase 1, developed by Arcus Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arcus Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| AB598 NCT05891171 | Phase 1 | Advanced Cancer |
Latest
No recent events.
Follow Ab598 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.